We are live on ! Find out more
Jane Street

Jane Street Portfolio holdings

AUM $777B
1-Year Est. Return 61.18%
 

Jane Street Group, founded in 2000 by Tim Reynolds, Rob Granieri, Marc Gerstein, and Michael Jenkins, is a New York City-based quantitative trading firm renowned for its technological prowess and collaborative problem-solving culture. Specializing in liquidity provision and market-making, it trades a vast array of financial products—including equities, bonds, options, and ETFs—across over 200 venues in 45 countries, handling trillions in securities annually. The firm, which employs over 2,600 people across offices in New York, London, Hong Kong, Amsterdam, Chicago, and Singapore, leverages advanced algorithms and a nearly 70-million-line OCaml codebase to dominate markets, notably ETFs, where it plays a critical role as an authorized participant. With net trading revenues exceeding $10 billion annually in recent years, including a record $10.6 billion in 2023, Jane Street has emerged as a secretive yet powerful force in global finance, outpacing traditional Wall Street giants like Goldman Sachs in trading profitability.

This Fund
S&P 500
This Quarter Est. Return
-0.58%
1 Year Est. Return
+61.18%
3 Year Est. Return
+147.64%
5 Year Est. Return
+157.48%
10 Year Est. Return
+594.2%
AUM
$9.81B
AUM Growth
+$1.94B
Cap. Flow
+$2.23B
Cap. Flow %
22.74%
Top 10 Hldgs %
22.56%
Holding
3,618
New
1,130
Increased
681
Reduced
654
Closed
1,133

Sector Composition

Rank Sector Weight
1 Energy 3.32%
2 Technology 3.01%
3 Communication Services 2.63%
4 Consumer Discretionary 2.61%
5 Financials 2.25%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
AMRS
2426
DELISTED
Amyris Inc.
AMRS
$43K ﹤0.01%
761
-1,560
-67% -$92.2K
CRDC
2427
DELISTED
CARDICA INC COM NEW (DE)
CRDC
$43K ﹤0.01%
4,027
-2,910
-42% -$33K
CRNT icon
2428
Ceragon Networks
CRNT
$197M
$42K ﹤0.01%
+17,573
New +$40.8K
PLUR icon
2429
Pluri
PLUR
$16.7M
$42K ﹤0.01%
182
-686
-79% -$156K
BGMS
2430
Bio Green Med Solution Inc
BGMS
$4.91M
0
WINT
2431
DELISTED
Windtree Therapeutics Inc
WINT
$41K ﹤0.01%
1,600
-4,902
-75% -$118K
CYTR
2432
DELISTED
CytRx Corp
CYTR
$40K ﹤0.01%
2,632
-1,907
-42% -$37.7K
HDSN
2433
Hudson Technologies
HDSN
$254M
$37K ﹤0.01%
11,058
-13,659
-55% -$41.3K
HL icon
2434
Hecla Mining
HL
$9.47B
$37K ﹤0.01%
14,849
-49,143
-77% -$154K
ZOOM
2435
DELISTED
ZOOM TECHNOLOGIES INC COM STK (DELAWARE)
ZOOM
$37K ﹤0.01%
13,681
ACGN
2436
DELISTED
Aceragen Inc
ACGN
$36K ﹤0.01%
115
-911
-89% -$328K
IPCI
2437
DELISTED
Intellipharmaceuticals International Inc.
IPCI
$36K ﹤0.01%
1,187
-2,789
-70% -$80.4K
ONCY
2438
DELISTED
ONCOLYTICS BIOTECH INC
ONCY
$36K ﹤0.01%
62,527
+24,051
+63% +$30.5K
IPAS
2439
DELISTED
Ipass Inc Common Stock
IPAS
$36K ﹤0.01%
+2,375
New +$33.1K
NG icon
2440
NovaGold Resources
NG
$2.56B
$33K ﹤0.01%
11,000
-8,464
-43% -$31.7K
PALI icon
2441
Palisade Bio
PALI
$330M
0
NETE
2442
DELISTED
NETEGRITY INC
NETE
$33K ﹤0.01%
+15,149
New +$33K
WLT
2443
CALL
DELISTED
WALTER ENERGY INC COM STK (DE)
WLT
$32K ﹤0.01%
+13,700
New +$70.9K
GYRE icon
2444
Gyre Therapeutics
GYRE
$641M
$29K ﹤0.01%
+15
New +$37.1K
IAG icon
2445
IAMGOLD
IAG
$8.2B
$29K ﹤0.01%
10,507
-48,070
-82% -$177K
SNOA icon
2446
Sonoma Pharmaceuticals
SNOA
$5.26M
$28K ﹤0.01%
13
-13
-50% -$30.2K
DAKP
2447
DELISTED
DAKOTA PLAINS HOLDINGS, INC. COMMON STOCK
DAKP
$28K ﹤0.01%
+11,808
New +$28.4K
LAS
2448
DELISTED
LENTUO INTL INC ADS REPSTG 2 ORD SHS (CYM)
LAS
$27K ﹤0.01%
+14,479
New +$35.6K
RDGT
2449
Ridgetech Inc
RDGT
$2.74M
0
THTI
2450
DELISTED
THT HEAT TRANSFER TECHNOLOGY, INC. COMMON STOCK
THTI
$26K ﹤0.01%
17,527
+1,038
+6% +$1.42K

Similar funds

Jane Street's Q3 2014 Portfolio in Review

As of Q3 2014, Jane Street held 3,618 positions worth $9.81B, up 25% from $7.86B the previous quarter. Its ten largest holdings account for 23% of the portfolio.

Jane Street deployed $2.23B of net new capital in Q3 2014, opening 1,130 new positions and adding to 681 existing holdings. Its largest new stake was iShares MSCI Emerging Markets ETF: 5,183,984 shares worth $215M.

By sector, the portfolio is most concentrated in Energy at 3.3% of assets, down from 4.3% a quarter earlier, followed by Technology and Communication Services.

On the sell side, the largest reduction was AstraZeneca, an estimated $127M trimmed.

  • Jane Street's largest Q3 2014 buy was iShares MSCI Emerging Markets ETF: 5,183,984 shares worth $215M.
  • Jane Street added most to KINDER MORGAN ENER PNTRS L.P. in Q3 2014, an estimated $81.1M increase.
  • Jane Street's biggest Q3 2014 reduction was AstraZeneca, cutting an estimated $127M.
  • Jane Street fully exited BP in Q3 2014, selling an estimated $71M.
  • Jane Street's ten largest holdings make up 23% of its $9.81B portfolio in Q3 2014.
  • Jane Street opened 1,130 new positions and closed 1,133 in Q3 2014.
  • Jane Street's portfolio value rose 25% quarter-over-quarter to $9.81B.

Based on Jane Street's 13F filing for Q3 2014, filed 14 Nov 2014.